RECURSION PHARMACEUTICALS, INC.

RXRX

RECURSION PHARMACEUTICALS, INC.

RXRX

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-18Shares Purchased (TTM):0Shares Sold (TTM):2,107,403

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:331,943,517Shares Outstanding:529,303,984Institutional Ownership Pct.:62.71%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	546	654	743	660	525	500	594	428	474	296	392	387
Restricted Cash Current	5	6	5	3	3	3	3	2	2	3	3	2
Other Receivables Net Current	14	14	25	22	22	46	49	2	3	3	3	3
Prepaid Expense Current	9	12	12	0	0	2	30	-	-	-	-	-
Other Assets Current	29	24	29	29	37	32	38	43	44	41	40	18
Assets Current	603	710	813	714	587	584	714	474	522	344	438	411
Restricted Cash Noncurrent	6	5	6	4	6	6	6	7	7	7	7	8
Property Plant And Equipment Net	90	96	104	112	120	127	141	84	84	87	87	86
Operating Lease Right Of Use Asset	40	43	45	48	50	53	66	48	44	36	34	34
Finance Lease Right Of Use Asset	-	19	20	22	23	25	26	27	29	-	0	-
Intangible Assets Net Excluding Goodwill	283	294	310	322	341	336	336	34	38	33	36	39
Goodwill	160	160	162	162	164	158	149	52	52	52	52	53
Deferred Income Tax Assets Net	1	1	1	1	1	2	2	-	-	-	0	-
Other Assets Noncurrent	12	12	13	15	9	15	9	0	0	0	0	0
Assets	1,213	1,340	1,474	1,400	1,302	1,305	1,449	726	776	558	654	631
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	13	20	18	14	19	25	22	2	4	5	4	4
Accrued Liabilities Current	57	54	70	53	64	57	82	41	33	26	47	40
Contract With Customer Liability Current	28	33	38	47	40	40	62	50	32	37	36	44
Notes Payable Current	-	-	-	-	-	-	-	-	-	0	0	1
Operating Lease Liability Current	13	13	13	12	12	12	14	8	9	6	6	5
Long Term Debt And Capital Lease Obligations Curre…	9	9	9	9	9	9	8	8	8	-	0	-
Liabilities Current	120	130	148	155	164	142	187	109	86	74	93	94
Contract With Customer Liability Noncurrent	113	115	114	111	126	130	119	16	29	37	51	51
Long Term Notes Payable	-	-	-	-	-	-	-	-	-	1	1	1
Operating Lease Liability Noncurrent	39	43	47	50	53	56	67	54	50	44	43	44
Long Term Debt And Capital Lease Obligations	5	7	10	12	14	16	19	21	23	-	1	-
Deferred Income Tax Liabilities Net	18	18	23	23	24	22	17	0	0	1	1	2
Other Liabilities Noncurrent	3	2	2	1	2	5	5	3	3	-	0	-
Liabilities	298	315	343	353	383	371	414	202	191	157	190	193
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	3,212	3,192	3,170	2,981	2,681	2,553	2,474	1,777	1,741	1,460	1,431	1,313
Retained Earnings Accumulated Deficit	-2,325	-2,194	-2,076	-1,968	-1,806	-1,634	-1,431	-1,252	-1,157	-1,059	-968	-875
Accumulated Other Comprehensive Income Loss Net Of…	28	27	37	34	44	14	-8	-	-	-	0	-
Stockholders Equity	915	1,025	1,131	1,047	919	934	1,035	525	584	401	463	438
Liabilities And Stockholders Equity	1,213	1,340	1,474	1,400	1,302	1,305	1,449	726	776	558	654	631
Common Class A	-	525	522	88	28	400	1,989	280	-230	230	1,989	208
Common Class B	-	5	5	-1	0	7	11	-0	-0	7	11	-0
Exchangeable Stock	-	1	1	0	0	0	0	0	0	0	0	-3
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000
Common Stock Shares Issued	534	531	528	492	433	406	397	286	281	238	234	216
Shares Outstanding	534	531	528	492	433	406	397	286	281	238	234	216

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.66%	2.62%	-13.70%	-	-	-	-	-	-	-	-	-
2025	-12.09%	5.78%	36.49%	-15.01%	-14.65%	9.22%	-6.65%	-14.31%	-4.64%	-13.79%	0.27%	-22.28%
2024	-4.17%	-13.19%	-3.36%	9.64%	5.12%	-2.41%	1.43%	6.03%	5.16%	-11.05%	-26.76%	-39.28%
2023	-	-	-	-21.04%	-33.77%	-54.29%	41.30%	88.53%	87.00%	-22.07%	-45.39%	-30.01%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.03	5.47	5.50	4.60	3.58	4.11	3.81	4.35	6.07	4.65	4.70	4.36
Quick Ratio	4.96	5.38	5.42	4.60	3.58	4.10	3.65	4.35	6.07	4.65	4.70	4.36
Working Capital	483.58M	579.86M	665.14M	559.00M	423.13M	442.16M	526.80M	365.28M	436.29M	269.70M	344.97M	316.40M
Leverage & Debt
Debt to Equity	0.33	0.31	0.30	0.34	0.42	0.40	0.40	0.38	0.33	0.39	0.41	0.44
Debt Ratio	0.25	0.23	0.23	0.25	0.29	0.28	0.29	0.28	0.25	0.28	0.29	0.31
Efficiency & Turnover
Asset Turnover TTM	0.04	0.05	0.05	0.04	0.06	0.06	0.06	0.10	0.07	0.08	0.07	0.08
Per Share Metrics
Diluted EPS TTM	-0.97	-1.06	-1.44	-1.60	-1.56	-1.43	-1.69	-1.34	-1.55	-1.50	-1.58	-1.37
Free Cash Flow Per Share TTM	-0.76	-0.62	-0.85	-0.70	-0.62	-0.99	-1.36	-1.18	-1.41	-1.40	-1.44	-1.29
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	3.48%	7.22%	4.99%	-59.01%	-3.51%	6.50%	23.12%	35.07%	17.15%	10.66%	4.46%	8.05%
Operating Profit Margin TTM	-991.72%	-881.32%	-867.87%	-1,656.17%	-1,005.81%	-960.08%	-814.09%	-604.70%	-796.54%	-814.39%	-785.33%	-659.02%
Net Profit Margin TTM	-945.92%	-842.93%	-863.35%	-1,637.81%	-1,004.91%	-961.32%	-788.02%	-579.51%	-755.37%	-765.90%	-735.99%	-617.74%
Growth Metrics
Net Revenue Growth (1Y)	-15.08%	11.07%	26.92%	-32.98%	30.14%	29.32%	32.00%	37.64%	-0.70%	-0.88%	11.88%	65.02%
Net Income Growth (1Y)	-20.06%	-2.61%	39.06%	89.42%	73.14%	62.31%	41.33%	29.12%	44.21%	42.31%	36.99%	18.49%
EPS Growth (1Y)	-37.34%	-25.89%	-14.78%	19.75%	0.47%	-4.89%	7.13%	-2.07%	19.93%	15.54%	15.69%	-4.12%
Valuation Metrics
P/E TTM	-3.77	-2.90	-2.84	-3.05	-3.25	-3.71	-4.00	-4.93	-4.84	-6.65	-6.25	-5.60
P/B TTM	2.14	1.59	1.62	2.08	2.30	2.28	1.79	3.55	3.11	5.87	4.42	3.74
P/S TTM	35.62	24.47	24.50	49.93	32.69	35.64	31.50	28.57	36.60	50.89	45.98	34.62
Market Cap	1.95B	1.62B	1.83B	2.18B	2.11B	2.13B	1.85B	1.86B	1.82B	2.35B	2.05B	1.64B
Enterprise Value	1.41B	976.23M	1.09B	1.53B	1.60B	1.65B	1.28B	1.46B	1.36B	2.05B	1.65B	1.24B
Calculated Values
Free Cash Flow TTM	-405.13M	-325.85M	-378.28M	-313.90M	-260.08M	-397.71M	-372.87M	-332.29M	-342.16M	-330.20M	-299.74M	-276.32M
Net Debt	-542.62M	-648.73M	-735.27M	-646.32M	-510.90M	-484.12M	-575.58M	-407.10M	-451.72M	-305.02M	-400.24M	-395.39M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Insider Transactions

2026-06-18Sale

Owner: Bumpus, Namandje

Title: -

Shares: 3,963

Price/Share: $3.18

Value: $12,602.34

Shares Owned: 127,632

Relationship: Director

Ownership: Direct

2026-06-05Sale

Owner: Khan, Najat

Title: CEO and President

Shares: 23,588

Price/Share: $3.58

Value: $84,445.04

Shares Owned: 2,175,796

Relationship: Director,Officer

Ownership: Direct

2026-06-05Sale

Owner: Gibson, Christopher

Title: -

Shares: 40,000

Price/Share: $3.62

Value: $144,800.00

Shares Owned: 883,735

Relationship: Director

Ownership: Direct

2026-06-03Sale

Owner: Bumpus, Namandje

Title: -

Shares: 4,386

Price/Share: $3.54

Value: $15,526.44

Shares Owned: 43,171

Relationship: Director

Ownership: Direct

2026-06-02Sale

Owner: Borgeson, Blake

Title: -

Shares: 30,000

Price/Share: $3.68

Value: $110,400.00

Shares Owned: 6,169,863

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-18	Bumpus, Namandje	Director	-	Direct	Sale	3,963	3.18	$12,602.34	127,632	4
2026-06-05	Khan, Najat	Director,Officer	CEO and President	Direct	Sale	23,588	3.58	$84,445.04	2,175,796	4
2026-06-05	Gibson, Christopher	Director	-	Direct	Sale	40,000	3.62	$144,800.00	883,735	4
2026-06-03	Bumpus, Namandje	Director	-	Direct	Sale	4,386	3.54	$15,526.44	43,171	4
2026-06-02	Borgeson, Blake	Director	-	Direct	Sale	30,000	3.68	$110,400.00	6,169,863	4
2026-05-22	Gibson, Christopher	Director	-	Direct	Sale	40,000	3.08	$123,200.00	883,735	4
2026-05-07	Gibson, Christopher	Director	-	Direct	Sale	40,000	3.37	$134,800.00	926,556	4
2026-05-05	Borgeson, Blake	Director	-	Direct	Sale	30,000	3.52	$105,600.00	6,199,863	4
2026-04-22	Gibson, Christopher	Director	-	Direct	Sale	40,000	3.61	$144,400.00	906,556	4
2026-04-07	Borgeson, Blake	Director	-	Direct	Sale	30,000	3.10	$93,000.00	6,229,863	4
2026-04-07	Gibson, Christopher	Director	-	Direct	Sale	40,000	3.10	$124,000.00	906,556	4
2026-03-23	Gibson, Christopher	Director	-	Direct	Sale	40,000	3.25	$130,000.00	906,556	4
2026-03-17	Taylor, Ben R	Officer	Chief Financial Officer	Direct	Sale	7,956	3.39	$26,970.84	1,180,318	4
2026-03-09	Khan, Najat	Director,Officer	CEO and President	Direct	Sale	28,298	3.35	$94,798.30	2,262,085	4
2026-03-03	Borgeson, Blake	Director	-	Direct	Sale	170,000	3.46	$588,200.00	6,259,863	4
2026-02-19	Gibson, Christopher	Director	-	Direct	Sale	40,000	3.46	$138,400.00	906,556	4
2026-02-18	Taylor, Ben R	Officer	Chief Financial Officer	Direct	Sale	13,426	3.08	$41,352.08	1,195,349	4
2026-02-04	Gibson, Christopher	Director	-	Direct	Sale	40,000	4.12	$164,800.00	913,839	4
2026-02-03	Borgeson, Blake	Director	-	Direct	Sale	220,000	4.20	$924,000.00	6,429,863	4
2026-01-20	Gibson, Christopher	Director	-	Direct	Sale	40,000	4.47	$178,800.00	913,839	4
2026-01-06	Borgeson, Blake	Director	-	Direct	Sale	220,000	4.36	$959,200.00	6,649,863	4
2026-01-05	Gibson, Christopher	Director	-	Direct	Sale	40,000	4.25	$170,000.00	933,839	4
2025-12-29	Taylor, Ben R	Officer	Chief Financial Officer	Direct	Sale	21,383	4.18	$89,380.94	761,550	4
2025-12-22	Khan, Najat	Director,Officer	Chief R&D Commercial Officer	Direct	Sale	124,403	4.41	$548,617.23	611,135	4
2025-12-19	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	40,000	4.50	$180,000.00	913,839	4
2025-12-04	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	40,000	4.63	$185,200.00	933,839	4
2025-12-02	Borgeson, Blake	Director	-	Direct	Sale	220,000	4.37	$961,400.00	6,869,863	4
2025-11-19	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	40,000	4.16	$166,400.00	913,839	4
2025-11-04	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	40,000	5.21	$208,400.00	974,229	4
2025-10-23	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	100,000	5.70	$570,000.00	954,229	4
2025-10-10	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	100,000	6.04	$604,000.00	974,229	4
2025-09-25	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	100,000	4.76	$476,000.00	954,229	4
2025-09-10	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	100,000	4.71	$471,000.00	974,229	4
2025-08-26	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	100,000	4.84	$484,000.00	954,229	4
2025-08-18	Khan, Najat	Director,Officer	Chief R&D Commercial Officer	Direct	Sale	36,599	5.52	$202,026.48	668,197	4
2025-08-11	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	500,300	5.28	$2,641,584.00	1,004,619	4
2025-03-27	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	138,574	6.04	$836,986.96	1,117,450	4
2025-03-05	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	20,000	6.58	$131,600.00	1,256,024	4
2025-02-06	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	20,000	8.12	$162,400.00	1,273,156	4
2025-01-10	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	20,000	7.05	$141,000.00	736,633	4
2024-12-05	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	20,000	7.12	$142,400.00	736,633	4
2024-11-14	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	20,000	7.35	$147,000.00	762,656	4
2024-11-13	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	15,000	7.66	$114,900.00	1,499,631	4
2024-11-12	Borgeson, Blake	Director	-	Direct	Sale	11,447	7.64	$87,455.08	7,066,113	4
2024-10-29	Borgeson, Blake	Director	-	Direct	Sale	11,447	6.72	$76,923.84	7,077,560	4
2024-10-24	Marriott, Tina	Officer	President and COO	Direct	Sale	6,000	6.31	$37,860.00	521,138	4
2024-10-15	Borgeson, Blake	Director	-	Direct	Sale	11,447	6.67	$76,351.49	7,089,007	4
2024-10-09	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	15,000	6.36	$95,400.00	1,450,881	4
2024-10-03	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	20,000	6.08	$121,600.00	762,656	4
2024-10-01	Borgeson, Blake	Director	-	Direct	Sale	11,447	6.22	$71,200.34	7,098,428	4
2024-09-26	Marriott, Tina	Officer	President and COO	Direct	Sale	6,000	7.00	$42,000.00	521,138	4
2024-09-17	Borgeson, Blake	Director	-	Direct	Sale	11,447	6.84	$78,297.48	7,109,875	4
2024-09-11	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	15,000	6.32	$94,800.00	1,402,131	4
2024-09-05	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	20,000	6.14	$122,800.00	762,656	4
2024-09-03	Borgeson, Blake	Director	-	Direct	Sale	11,447	6.27	$71,772.69	7,121,322	4
2024-08-29	Marriott, Tina	Officer	President and COO	Direct	Sale	6,000	7.56	$45,360.00	521,138	4
2024-08-20	Borgeson, Blake	Director	-	Direct	Sale	11,447	7.12	$81,502.64	7,132,769	4
2024-08-13	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	15,000	6.35	$95,250.00	1,340,968	4
2024-08-08	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	20,000	6.50	$130,000.00	758,738	4
2024-08-06	Borgeson, Blake	Director	-	Direct	Sale	11,447	6.82	$78,068.54	7,144,216	4
2024-07-25	Marriott, Tina	Officer	President and COO	Direct	Sale	6,000	8.13	$48,780.00	535,457	4
2024-07-23	Borgeson, Blake	Director	-	Direct	Sale	11,447	8.48	$97,070.56	7,155,663	4
2024-07-11	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	50,000	7.47	$373,500.00	758,738	4
2024-07-10	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	15,000	7.24	$108,600.00	1,316,593	4
2024-07-09	Borgeson, Blake	Director	-	Direct	Sale	11,447	7.32	$83,792.04	7,167,110	4
2024-06-27	Marriott, Tina	Officer	President and COO	Direct	Sale	6,000	7.22	$43,320.00	535,457	4
2024-06-25	Borgeson, Blake	Director	-	Direct	Sale	11,447	9.51	$108,860.97	7,177,116	4
2024-06-14	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	15,000	9.27	$139,050.00	1,267,843	4
2024-06-11	Borgeson, Blake	Director	-	Direct	Sale	11,447	8.45	$96,727.15	7,188,563	4
2024-06-06	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	50,000	9.00	$450,000.00	708,738	4
2024-05-30	Marriott, Tina	Officer	President and COO	Direct	Sale	3,000	8.78	$26,340.00	535,457	4
2024-05-28	Borgeson, Blake	Director	-	Direct	Sale	11,447	9.17	$104,968.99	7,186,913	4
2024-05-14	Borgeson, Blake	Director	-	Direct	Sale	20,054	10.12	$202,946.48	7,198,360	4
2024-05-02	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	50,000	8.47	$423,500.00	834,820	4
2024-04-30	Borgeson, Blake	Director	-	Direct	Sale	11,447	7.95	$91,003.65	7,218,414	4
2024-04-25	Marriott, Tina	Officer	President and COO	Direct	Sale	3,000	7.67	$23,010.00	543,231	4
2024-04-17	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	23,124	7.58	$175,279.92	1,231,055	4
2024-04-16	Borgeson, Blake	Director	-	Direct	Sale	11,447	7.66	$87,684.02	7,229,861	4
2024-04-04	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	40,000	9.02	$360,800.00	938,524	4
2024-04-02	Borgeson, Blake	Director	-	Direct	Sale	11,447	8.82	$100,962.54	7,241,308	4
2024-03-28	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	40,000	10.10	$404,000.00	1,043,524	4
2024-03-21	Marriott, Tina	Officer	President and COO	Direct	Sale	8,000	11.02	$88,160.00	639,982	4
2024-03-19	Borgeson, Blake	Director	-	Direct	Sale	20,054	10.79	$216,382.66	7,252,755	4
2024-03-13	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	25,000	11.03	$275,750.00	1,204,179	4
2024-03-06	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	36,319	11.86	$430,743.34	1,108,524	4
2024-03-05	Borgeson, Blake	Director	-	Direct	Sale	20,054	12.06	$241,851.24	7,272,809	4
2024-02-22	Marriott, Tina	Officer	President and COO	Direct	Sale	8,000	14.90	$119,200.00	639,982	4
2024-02-20	Borgeson, Blake	Director	-	Direct	Sale	20,054	12.68	$254,284.72	7,292,863	4
2024-02-14	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	25,000	10.70	$267,500.00	1,186,351	4
2024-02-07	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	48,272	9.22	$445,067.84	774,703	4
2024-02-06	Borgeson, Blake	Director	-	Direct	Sale	11,447	9.30	$106,457.10	7,312,917	4
2024-01-25	Larson, Tina Marriott	Officer	President and COO	Direct	Sale	8,000	10.35	$82,800.00	414,548	4
2024-01-23	Borgeson, Blake	Director	-	Direct	Sale	20,054	10.58	$212,171.32	7,324,364	4
2024-01-17	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	25,000	10.25	$256,250.00	981,014	4
2024-01-16	Virani, Shafique	Officer	Chief Business Officer	Direct	Sale	18,000	10.93	$196,740.00	136,748	4
2024-01-09	Li, Dean Y	Director	-	Indirect	Sale	29,000	13.84	$401,360.00	421,000	4
2024-01-09	Borgeson, Blake	Director	-	Direct	Sale	20,054	13.51	$270,929.54	7,344,418	4
2024-01-03	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	30,853	9.49	$292,794.97	791,725	4
2023-12-28	Larson, Tina Marriott	Officer	President and COO	Direct	Sale	8,000	10.58	$84,640.00	414,548	4
2023-12-26	Borgeson, Blake	Director	-	Direct	Sale	20,054	10.63	$213,174.02	7,364,472	4
2023-12-15	Virani, Shafique	Officer	Chief Business Officer	Direct	Sale	18,000	9.60	$172,800.00	136,748	4
2023-12-14	Dar, Zavain	Director	-	Direct	Sale	20,141	9.00	$181,269.00	53,823	4
2023-12-13	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	25,000	7.59	$189,750.00	956,014	4
2023-12-12	Borgeson, Blake	Director	-	Direct	Sale	11,447	7.40	$84,707.80	7,384,526	4
2023-12-06	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	59,829	7.49	$448,119.21	791,328	4
2023-11-28	Borgeson, Blake	Director	-	Direct	Sale	11,447	6.72	$76,923.84	7,395,973	4
2023-11-16	Larson, Tina Marriott	Officer	President and COO	Direct	Sale	3,000	6.76	$20,280.00	413,404	4
2023-11-15	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	25,000	7.44	$186,000.00	938,186	4
2023-11-15	Virani, Shafique	Officer	Chief Business Officer	Direct	Sale	18,000	6.51	$117,180.00	140,351	4
2023-11-14	Borgeson, Blake	Director	-	Direct	Sale	8,885	6.32	$56,153.20	7,407,420	4
2023-11-01	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	37,177	5.20	$193,320.40	836,820	4
2023-10-31	Borgeson, Blake	Director	-	Direct	Sale	8,885	5.27	$46,823.95	7,416,305	4
2023-10-26	Larson, Tina Marriott	Officer	President and COO	Direct	Sale	3,000	5.63	$16,890.00	418,782	4
2023-10-17	Borgeson, Blake	Director	-	Direct	Sale	8,885	6.58	$58,463.30	7,425,190	4
2023-10-16	Virani, Shafique	Officer	Chief Business Officer	Direct	Sale	18,000	6.30	$113,400.00	140,351	4
2023-10-11	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	25,000	6.85	$171,250.00	913,186	4
2023-10-04	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	59,794	7.21	$431,114.74	842,747	4
2023-10-03	Borgeson, Blake	Director	-	Direct	Sale	8,885	7.29	$64,771.65	7,434,075	4
2023-09-28	Larson, Tina Marriott	Officer	President and COO	Direct	Sale	3,000	7.72	$23,160.00	418,782	4
2023-09-19	Borgeson, Blake	Director	-	Direct	Sale	8,885	8.36	$74,278.60	7,442,960	4
2023-09-15	Virani, Shafique	Officer	Chief Business Officer	Direct	Sale	18,000	8.66	$155,880.00	140,351	4
2023-09-13	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	25,000	8.69	$217,250.00	888,186	4
2023-09-06	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	33,765	8.78	$296,456.70	871,291	4
2023-09-05	Borgeson, Blake	Director	-	Direct	Sale	8,885	8.79	$78,099.15	7,451,845	4
2023-08-24	Larson, Tina Marriott	Officer	President and COO	Direct	Sale	3,000	9.04	$27,120.00	418,782	4
2023-08-22	Borgeson, Blake	Director	-	Direct	Sale	8,885	8.91	$79,165.35	7,460,730	4
2023-08-16	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	25,000	8.90	$222,500.00	863,186	4
2023-08-15	Virani, Shafique	Officer	Chief Business Officer	Direct	Sale	18,000	9.25	$166,500.00	140,351	4
2023-08-08	Borgeson, Blake	Director	-	Direct	Sale	17,770	11.39	$202,400.30	7,469,615	4
2023-08-02	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	65,015	13.19	$857,547.85	890,719	4
2023-07-27	Larson, Tina Marriott	Officer	President and COO	Direct	Sale	8,000	13.58	$108,640.00	424,160	4
2023-07-26	Virani, Shafique	Officer	Chief Business Officer	Direct	Sale	20,000	14.41	$288,200.00	143,954	4
2023-07-25	Borgeson, Blake	Director	-	Direct	Sale	18,719	14.61	$273,484.59	7,487,385	4
2023-07-19	Secora, Michael	Officer	Chief Financial Officer	Direct	Sale	25,000	15.24	$381,000.00	842,913	4
2023-07-18	Virani, Shafique	Officer	Chief Business Officer	Direct	Sale	30,000	13.74	$412,200.00	143,954	4
2023-07-13	Burrell, Terry-Ann	Director	-	Direct	Sale	8,275	12.59	$104,182.25	54,847	4
2023-07-12	Gibson, Christopher	Director,Officer	Chief Executive Officer	Direct	Sale	31,818	12.35	$392,952.30	915,810	4
2023-07-11	Borgeson, Blake	Director	-	Direct	Sale	8,885	6.89	$61,217.65	7,520,104	4
2023-06-29	Larson, Tina Marriott	Officer	President and COO	Direct	Sale	3,000	7.49	$22,470.00	424,160	4
2023-06-27	Borgeson, Blake	Director	-	Direct	Sale	8,885	7.39	$65,660.15	7,528,989	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Institutional Ownership

No data available for chart

2026-03-31

62.71%

Inst. Shares: 331,943,517

Shares Outstanding: 529,303,984

2025-12-31

71.66%

Inst. Shares: 320,638,553

Shares Outstanding: 447,446,109

2025-09-30

72.43%

Inst. Shares: 323,768,773

Shares Outstanding: 446,988,046

2025-06-30

73.34%

Inst. Shares: 306,093,961

Shares Outstanding: 417,361,147

2025-03-31

74.80%

Inst. Shares: 301,281,467

Shares Outstanding: 402,771,972

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	331,943,517	529,303,984	62.71%
2025-12-31	320,638,553	447,446,109	71.66%
2025-09-30	323,768,773	446,988,046	72.43%
2025-06-30	306,093,961	417,361,147	73.34%
2025-03-31	301,281,467	402,771,972	74.80%
2024-12-31	302,289,891	274,207,146	110.24%
2024-09-30	258,207,078	282,583,048	91.37%
2024-06-30	249,696,779	242,196,409	103.10%
2024-03-31	208,162,610	236,019,349	88.20%
2023-12-31	203,942,591	207,853,702	98.12%
2023-09-30	146,160,892	214,327,186	68.20%
2023-06-30	119,625,215	201,415,475	59.39%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

RECURSION PHARMACEUTICALS, INC. (RXRX) — SEC Financial Statements & Analysis

RECURSION PHARMACEUTICALS, INC. (RXRX) is a biological products, (no diagnostic substances) company, incorporated in DE. RECURSION PHARMACEUTICALS, INC. trades on Nasdaq as: RXRX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), RECURSION PHARMACEUTICALS, INC. reported a -15.08% year-over-year revenue growth, a Gross Profit Margin of 3.48% (TTM), a Debt-to-Equity ratio of 0.33x, a Price-to-Sales (P/S) ratio of 35.62x (TTM), a Price-to-Book (P/B) ratio of 2.14x (TTM), at a market cap of $1.95B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -15.08%
Gross Profit Margin TTM: 3.48%
Debt To Equity: 0.33x
P/S TTM: 35.62x
P/B TTM: 2.14x
Market Cap: $1.95B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is RECURSION PHARMACEUTICALS, INC. in?

RECURSION PHARMACEUTICALS, INC. (RXRX) operates in the Biological Products, (No Diagnostic Substances) industry.

What is RXRX's market cap?

RECURSION PHARMACEUTICALS, INC. (RXRX) has a market capitalization of $1.95B as of 2026-06-30.

What exchange does RXRX trade on?

RECURSION PHARMACEUTICALS, INC. (RXRX) trades on the Nasdaq.

Where is RECURSION PHARMACEUTICALS, INC. incorporated?

RECURSION PHARMACEUTICALS, INC. is incorporated in DE.